These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 1652171

  • 1. Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis.
    Sogani PC.
    Urol Clin North Am; 1991 Aug; 18(3):561-73. PubMed ID: 1652171
    [Abstract] [Full Text] [Related]

  • 2. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A, Pfister D.
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH, Stein JP, Skinner DG.
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [Abstract] [Full Text] [Related]

  • 5. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann KU, Krege S, Lossin P, Weissbach L, German Testicular Cancer Study Group.
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [Abstract] [Full Text] [Related]

  • 6. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D, Farmakis D, Pectasides M.
    Oncology; 2006 May; 71(3-4):151-8. PubMed ID: 17646698
    [Abstract] [Full Text] [Related]

  • 7. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J.
    J Clin Oncol; 2007 Dec 10; 25(35):5597-602. PubMed ID: 18065732
    [Abstract] [Full Text] [Related]

  • 8. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW.
    Cancer; 1998 Sep 01; 83(5):1002-11. PubMed ID: 9731905
    [Abstract] [Full Text] [Related]

  • 9. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
    Eggener SE, Carver BS, Sharp DS, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Urol; 2007 Mar 01; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
    [Abstract] [Full Text] [Related]

  • 10. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA, Bokemeyer C, Serth J, Machtens S, Höfner K, Jonas U.
    Urologe A; 1996 Jan 01; 35(1):35-45. PubMed ID: 8851847
    [Abstract] [Full Text] [Related]

  • 11. Role of primary chemotherapy in stage I and low-volume stage II nonseminomatous germ-cell testis tumors.
    Sternberg CN.
    Urol Clin North Am; 1993 Feb 01; 20(1):93-109. PubMed ID: 8382000
    [Abstract] [Full Text] [Related]

  • 12. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
    Yoon GH, Stein JP, Skinner DG.
    Urol Oncol; 2005 Feb 01; 23(3):168-77. PubMed ID: 15907716
    [Abstract] [Full Text] [Related]

  • 13. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE.
    J Urol; 1999 Apr 01; 161(4):1148-52. PubMed ID: 10081858
    [Abstract] [Full Text] [Related]

  • 14. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD.
    Cancer; 1996 Aug 01; 78(3):480-6. PubMed ID: 8697394
    [Abstract] [Full Text] [Related]

  • 15. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J.
    J Urol; 2005 Aug 01; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [Abstract] [Full Text] [Related]

  • 16. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D, Ondrusova M, Hornak M, Matoska J.
    Neoplasma; 2007 Aug 01; 54(5):437-42. PubMed ID: 17688374
    [Abstract] [Full Text] [Related]

  • 17. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    J Urol; 2008 Jan 01; 179(1):163-6. PubMed ID: 18001800
    [Abstract] [Full Text] [Related]

  • 18. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ.
    Arch Esp Urol; 2002 Oct 01; 55(8):927-36. PubMed ID: 12455283
    [Abstract] [Full Text] [Related]

  • 19. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
    Stephenson AJ, Bosl GJ, Motzer RJ, Kattan MW, Stasi J, Bajorin DF, Sheinfeld J.
    J Clin Oncol; 2005 Apr 20; 23(12):2781-8. PubMed ID: 15837993
    [Abstract] [Full Text] [Related]

  • 20. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP.
    Hematol Oncol Clin North Am; 1991 Dec 20; 5(6):1127-42. PubMed ID: 1663937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.